DK1117440T3 - Farmaceutiske sammensætninger indeholdende paclitaxel - Google Patents
Farmaceutiske sammensætninger indeholdende paclitaxelInfo
- Publication number
- DK1117440T3 DK1117440T3 DK99945661T DK99945661T DK1117440T3 DK 1117440 T3 DK1117440 T3 DK 1117440T3 DK 99945661 T DK99945661 T DK 99945661T DK 99945661 T DK99945661 T DK 99945661T DK 1117440 T3 DK1117440 T3 DK 1117440T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing paclitaxel
- paclitaxel
- long term
- Prior art date
Links
- 229930012538 Paclitaxel Natural products 0.000 title abstract 2
- 229960001592 paclitaxel Drugs 0.000 title abstract 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/165,930 US5922754A (en) | 1998-10-02 | 1998-10-02 | Pharmaceutical compositions containing paclitaxel |
| PCT/US1999/021024 WO2000020036A1 (en) | 1998-10-02 | 1999-09-14 | Pharmaceutical compositions containing paclitaxel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1117440T3 true DK1117440T3 (da) | 2003-12-01 |
Family
ID=22601068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99945661T DK1117440T3 (da) | 1998-10-02 | 1999-09-14 | Farmaceutiske sammensætninger indeholdende paclitaxel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5922754A (de) |
| EP (1) | EP1117440B1 (de) |
| JP (1) | JP2002526424A (de) |
| AT (1) | ATE246514T1 (de) |
| AU (1) | AU759034B2 (de) |
| CA (1) | CA2345729A1 (de) |
| DE (1) | DE69910230T2 (de) |
| DK (1) | DK1117440T3 (de) |
| ES (1) | ES2205879T3 (de) |
| PT (1) | PT1117440E (de) |
| WO (1) | WO2000020036A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1000347B (el) * | 1988-12-21 | 1992-06-25 | Ortho Diagnostic Systems Inc | Μεθοδος παραγωγης νουκλεοτιδικων ανιχνευτων χρησιμοποιωντας ενα συμπληρωμα γεφυρωσεως. |
| US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| KR100330373B1 (ko) * | 1996-05-28 | 2002-11-07 | 주식회사한국신약 | 탁솔을 함유한 주사용 약제 조성물 |
| KR19990075621A (ko) * | 1998-03-23 | 1999-10-15 | 임성주 | 경사 평판형 배양조 |
| US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
| US6071952A (en) * | 1998-12-02 | 2000-06-06 | Mylan Pharmaceuticals, Inc. | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
| MXPA01009900A (es) | 2000-02-02 | 2003-08-20 | Univ Florida State Res Found | Formulaciones de taxano que tienen solubilidad mejorada. |
| US8618085B2 (en) * | 2000-04-28 | 2013-12-31 | Koasn Biosciences Incorporated | Therapeutic formulations of desoxyepothilones |
| US7550157B2 (en) | 2000-05-12 | 2009-06-23 | Samyang Corporation | Method for the preparation of polymeric micelle via phase separation of block copolymer |
| US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
| DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| KR100774366B1 (ko) * | 2001-09-10 | 2007-11-08 | 주식회사 중외제약 | 파클리탁셀 주사제 조성물 |
| AU2002351169B2 (en) * | 2001-11-26 | 2007-09-20 | Intas Pharmaceuticals Limited | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| AU2002353118A1 (en) * | 2001-12-11 | 2003-07-24 | Dor Biopharma, Inc. | Lipid particles and suspensions and uses thereof |
| DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| BRPI0406647A (pt) * | 2003-01-06 | 2005-12-06 | Angiochem Inc | Método para transportar um composto através da barreira sanguìnea do cérebro |
| US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
| US7557182B2 (en) * | 2005-02-18 | 2009-07-07 | Angiochem Inc. | Molecules for transporting a compound across the blood-brain barrier |
| EP1904052A4 (de) * | 2005-06-17 | 2008-12-10 | Hospira Australia Pty Ltd | Flüssige pharmazeutische formulierungen von docetaxel |
| JP5436856B2 (ja) | 2005-07-15 | 2014-03-05 | アンジオケム インコーポレーティッド | 薬学的複合体における担体としてのアプロチニンポリペプチドの使用 |
| AR054215A1 (es) | 2006-01-20 | 2007-06-13 | Eriochem Sa | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
| CN101573111A (zh) * | 2006-10-31 | 2009-11-04 | 惠氏公司 | 磷脂酶抑制剂的制剂 |
| US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| EP2205215A2 (de) * | 2007-10-01 | 2010-07-14 | Intas Pharmaceuticals Limited | Absolut ethanolfreie injizierbare docetaxelzusammensetzung |
| AR063111A1 (es) | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
| US20090098168A1 (en) * | 2007-10-08 | 2009-04-16 | The Regents Of The University Of California | Multiple-layer microbubble liposphere drug delivery vehicle and system |
| KR101053780B1 (ko) * | 2008-02-29 | 2011-08-02 | 동아제약주식회사 | 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물 |
| TR201905480T4 (tr) * | 2008-04-18 | 2019-05-21 | Angiochem Inc | Paklitaksel, paklitaksel analogları veya paklitaksel konjugatlarının farmasötik bileşimleri ve ilgili preparasyon ve kullanım yöntemleri. |
| ES2344674B1 (es) | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
| WO2010023321A1 (en) * | 2008-09-01 | 2010-03-04 | Stragen Pharma S.A. | Liquid formulation containing a taxane derivative |
| BRPI0920209A2 (pt) | 2008-10-15 | 2015-12-22 | Angiochem Inc | conjugados de agonistas de glp-1 e usos dos mesmos |
| MX2011004019A (es) | 2008-10-15 | 2011-06-24 | Angiochem Inc | Conjugados de etoposido y doxorubicina para entrega de farmacos. |
| CA2745524C (en) | 2008-12-05 | 2020-06-09 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
| US7862716B2 (en) * | 2009-04-13 | 2011-01-04 | Sielc Technologies Corporation | HPLC schematic with integrated sample cleaning system |
| WO2010121379A1 (en) | 2009-04-20 | 2010-10-28 | Angiochem Inc | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
| AU2010268726A1 (en) | 2009-07-02 | 2012-01-19 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
| FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
| CN102151243B (zh) * | 2010-12-29 | 2013-06-05 | 辰欣药业股份有限公司 | 一种紫杉醇注射液及其制备方法 |
| CN103330941B (zh) * | 2013-07-15 | 2014-11-19 | 贺金凤 | 一种紫杉醇注射剂的药物组合物 |
| US20160346221A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
| DK3307326T3 (da) | 2015-06-15 | 2020-10-19 | Angiochem Inc | Fremgangsmåder til behandling af leptomeningeal karcinomatose |
| TWI838700B (zh) * | 2015-09-30 | 2024-04-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3243393A (en) * | 1991-12-10 | 1993-07-19 | Rush - Presbyterian - St. Luke's Medical Center | Methods and compositions for reducing multi-drug resistance |
| ES2224200T3 (es) * | 1992-11-27 | 2005-03-01 | Mayne Pharma (Usa) Inc. | Composicion inyectable estable de paclitaxel. |
| FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
| TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| WO1996011007A1 (en) * | 1994-10-05 | 1996-04-18 | Glaxo Wellcome Inc. | Parenteral pharmaceutical compositions containing gf120918a |
| US5681846A (en) * | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
| EP0876145A4 (de) * | 1995-12-21 | 1999-04-21 | Genelabs Tech Inc | Taxanzusammensetzung und verfahren |
| ATE265847T1 (de) * | 1997-07-29 | 2004-05-15 | Upjohn Co | Selbstemulgierbare formulierung enthaltend lipophile verbindungen |
-
1998
- 1998-10-02 US US09/165,930 patent/US5922754A/en not_active Expired - Fee Related
-
1999
- 1999-09-14 JP JP2000573394A patent/JP2002526424A/ja not_active Withdrawn
- 1999-09-14 AT AT99945661T patent/ATE246514T1/de not_active IP Right Cessation
- 1999-09-14 WO PCT/US1999/021024 patent/WO2000020036A1/en not_active Ceased
- 1999-09-14 EP EP99945661A patent/EP1117440B1/de not_active Expired - Lifetime
- 1999-09-14 AU AU58225/99A patent/AU759034B2/en not_active Ceased
- 1999-09-14 CA CA002345729A patent/CA2345729A1/en not_active Abandoned
- 1999-09-14 ES ES99945661T patent/ES2205879T3/es not_active Expired - Lifetime
- 1999-09-14 PT PT99945661T patent/PT1117440E/pt unknown
- 1999-09-14 DK DK99945661T patent/DK1117440T3/da active
- 1999-09-14 DE DE69910230T patent/DE69910230T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2205879T3 (es) | 2004-05-01 |
| DE69910230D1 (de) | 2003-09-11 |
| WO2000020036A1 (en) | 2000-04-13 |
| AU759034B2 (en) | 2003-04-03 |
| EP1117440B1 (de) | 2003-08-06 |
| PT1117440E (pt) | 2003-12-31 |
| ATE246514T1 (de) | 2003-08-15 |
| EP1117440A1 (de) | 2001-07-25 |
| US5922754A (en) | 1999-07-13 |
| DE69910230T2 (de) | 2004-06-09 |
| JP2002526424A (ja) | 2002-08-20 |
| AU5822599A (en) | 2000-04-26 |
| CA2345729A1 (en) | 2000-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1117440T3 (da) | Farmaceutiske sammensætninger indeholdende paclitaxel | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| SE0102315D0 (sv) | Compounds | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| TR200103575T2 (tr) | Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler | |
| EP1100522A4 (de) | Verabreichung aktiver wirkstoffe über die lunge | |
| DE50010115D1 (de) | Zusammensetzung und verfahren zur entkeimung von luft | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| BR0109943A (pt) | Composições farmacêuticas | |
| DE69725825D1 (de) | 5-HT1F-Agonisten | |
| AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
| DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
| SE9201628D0 (sv) | Pharmaceutical composition | |
| CY1105009T1 (el) | Συνθεση καχαλαλιδης f | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| MXPA03011128A (es) | Composicion de sabor y fragancia. | |
| ATE305517T1 (de) | Neurotrypsin | |
| ID25478A (id) | Agonis 5-ht1f | |
| NO20021429D0 (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
| DE69900466D1 (de) | Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen | |
| MXPA03010821A (es) | Composiciones de aroma y fragancias. | |
| DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
| ATE317384T1 (de) | Lta4 hydrolase-hemmer |